Mindray Medical International (MR) Tops Q4 EPS by 7c; Issues FY13 Outlook
Tweet Send to a Friend
Mindray Medical International (NYSE: MR) reported Q4 EPS of $0.51, $0.07 better than the analyst estimate of $0.44. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
